Larimar Therapeutics Inc

Market Cap

$365M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.17-$0.30 (-8.65%)

Jun 5, 2026

52W High $5.9552W Low $2.42

Company Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2...

CEO

—

IPO Date

Jun 19, 2014

Website

www.larimartx.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$166M

EPS (Diluted)

Free Cash Flow

-$131M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 14, 2026

FY 2025

Mar 19, 2026

Q4 2025

Mar 19, 2026

$0-100.0%

Q3 2025

Nov 5, 2025

Q2 2025

Aug 14, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee